Vitadex Pharmaceutical Private Limited
About Vitadex Pharmaceutical Private Limited
Data last updated:
Vitadex Pharmaceutical Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2020PTC115998. Its GSTIN is 24AAHCV5699N1ZE (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Kailashben Sanjaykumar Shah and Surekhaben Vipinchandra Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop C/3 Mepal – 9 Nr. Sai Srushti Palanpur, Surat, Gujarat, India – 395009.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.49 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹33.68 Lakh (net margin -22.6%) and EBITDA of ₹72.98 Lakh (EBITDA margin 49%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
As per MCA filings, the company has open charges of ₹3 Cr on record.
Company details
Contact details
Vitadex Pharmaceutical Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop C/3 Mepal – 9 Nr. Sai Srushti Palanpur, Surat, Gujarat, India – 395009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vitadex Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vitadex Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vitadex Pharmaceutical Private Limited, buy the company report.
Financials of Vitadex Pharmaceutical Private Limited
FY 2025 filings availableVitadex Pharmaceutical Private Limited reported revenue of ₹1.49 Cr (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 29% growth in the latest year. EBITDA rose 281% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹72.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹33.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 49% | ||||
| Net Profit Margin | -22.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vitadex Pharmaceutical Private Limited, buy the company report.
Board of directors of Vitadex Pharmaceutical Private Limited
Vitadex Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kailashben Sanjaykumar Shah | Director | 31 Aug 2020 | 6 Years 2 Months | Current |
| Surekhaben Vipinchandra Shah | Director | 31 Aug 2020 | 6 Years 2 Months | Current |
| Rachana Jitendra Shah | Director | 31 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Vitadex Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meqte Sales and Services Private Limited | ₹1.5 Cr (FY 2024) | 0.0% | Patna, Bihar, India | |||
| Sonskyn Pharmaceuticals Private Limited | ₹1.5 Cr (FY 2025) | 34.0% | Indira Nagar, Uttar Pradesh, India | |||
| HNF Care Private Limited | ₹1.49 Cr (FY 2025) | 85.0% | Sri Ganganagar, Rajasthan, India | |||
| Vitadex Pharmaceutical Private Limitedthis company | ₹1.49 Cr (FY 2025) | -₹33.68 Lakh | -22.6% | 29.0% | Surat, Gujarat, India | |
| Meclon Pharmaceuticals Private Limited | ₹1.49 Cr (FY 2023) | 210.0% | Bangalore, Karnataka, India | |||
| Actiff Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2019) | 31.0% | Nallasopara West, Maharashtra, India |
To see the full peer comparison of Vitadex Pharmaceutical Private Limited, buy the company report.
Auditor
Vitadex Pharmaceutical Private Limited is audited by D. V. BARFIWALA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D. V. BARFIWALA & CO. | FY 2023 | 118936W |
Shareholding
The shareholding of Vitadex Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Vitadex Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Dec 2023 | 100839839 | Others | ₹3 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Vitadex Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vitadex Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vitadex Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Vitadex Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCV5699N1ZE | Gujarat | Active | 22 Sep 2020 |
To see the full GST registrations and return filing status of Vitadex Pharmaceutical Private Limited, buy the company report.
Recent activity
Vitadex Pharmaceutical Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Kailashben Sanjaykumar Shah was appointed as Director on 31 Aug 2020.
Frequently asked questions
Vitadex Pharmaceutical is an active private limited company based in Surat, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 August 2020 (6+ years old) and is registered under CIN U24100GJ2020PTC115998.
Vitadex Pharmaceutical has 3 current directors:
- Kailashben Sanjaykumar Shah - Director
- Surekhaben Vipinchandra Shah - Director
- Rachana Jitendra Shah - Director
The latest financial statements of Vitadex Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Vitadex Pharmaceutical is 24AAHCV5699N1ZE, registered in Gujarat.
The CIN (Corporate Identification Number) of Vitadex Pharmaceutical is U24100GJ2020PTC115998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vitadex Pharmaceutical was incorporated on 31 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Vitadex Pharmaceutical by revenue are Meqte Sales and Services Private Limited, Sonskyn Pharmaceuticals Private Limited, HNF Care Private Limited, Meclon Pharmaceuticals Private Limited, Actiff Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kailashben Sanjaykumar Shah was appointed as Director on 31 Aug 2020. Rachana Jitendra Shah was appointed as Director on 31 Aug 2020. Surekhaben Vipinchandra Shah was appointed as Director on 31 Aug 2020.
The registered office of Vitadex Pharmaceutical is at Shop C3 Mepal – 9 Nr. Sai Srushti Palanpur, Surat, Gujarat, India – 395009.
Vitadex Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Vitadex Pharmaceutical has open charges of ₹3 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
